White Paper

AI in Healthcare Operations: Improving Patient Outcomes

Admin — Mon, 23 Mar 2026 04:35:36 GMT

Discover how leading health systems are using AI to cut diagnosis times, reduce readmissions, and unlock operational savings.

Scalable SaaS Solutions for Pharma Incentive Compensation

Admin — Tue, 17 Mar 2026 06:39:59 GMT

From Fragmented to Future-Ready

How GCCs Can Lead Global IC Transformation with SaaS and AI

Global pharmaceutical incentive compensation is under mounting pressure. Siloed tools, inconsistent plans, and reliance on IT are no longer sustainable in a world that demands speed, transparency, and real-time insights. Rising compliance requirements, escalating costs, and growing expectations for AI-enabled decision-making are accelerating the need for change.

The Rise of Agentic AI in Rapid Cycle RWE Analytics for Pharma

Admin — Thu, 29 Jan 2026 10:47:12 GMT

Real world evidence (RWE) has become more critical than ever in life sciences. Yet traditional analytics approaches often leave meaningful insights hidden—stuck behind slow processes or buried in unstructured data. These approaches are constrained by tools that can’t keep pace with modern demands. This white paper explores how agentic AI is reshaping rapid-cycle RWE generation, enabling organizations to uncover deeper insights, design agile studies, and elevate decision-making with unprecedented speed and precision.

The Data Flywheel: AI & Data Products in Life Sciences

Admin — Thu, 29 Jan 2026 05:14:05 GMT

A top-5 pharmaceutical company cut business rule duplication by 60% and achieved 40% faster data-to-insights in under 5 months. A top-10 pharma consolidated 5 analytical platforms into 1, serving 950+ users from a single source of truth.

Agentic AI for Clinical Trial Site Selection & Intelligence

Admin — Wed, 24 Dec 2025 10:37:20 GMT

Reimagining site selection, enrollment, and trial execution with intelligent AI agents.

Clinical trials are becoming more complex, costlier, and competitive. Finding the right site to conduct a trial is tricky. Finding the patients to fill it can be even harder. Now throw fragmented data and manual decision-making on top of it.

New Drug Approvals 2025: FDA Guidance on AI and RWE

Admin — Thu, 18 Dec 2025 05:00:00 GMT

Regulatory changes are happening at an unprecedented pace. Emerging AI guidance, workforce cuts, and rising payer expectations are redefining how therapies reach patients. Discover what today’s transformations mean for sponsors and how to stay ahead with this point of view paper.

Redefining Commercial Insights in Pharma with Data Products

Admin — Tue, 28 Oct 2025 11:59:16 GMT

For commercial pharma leaders, data’s true power is realized where decisions happen: at the edge.
Gilead built that connection, transforming global strategy into local execution.

Rare Disease Forecasting: Why Projections Fail & How to Fix Them

Admin — Wed, 15 Oct 2025 11:06:30 GMT

Accurate forecasting in rare and ultra-rare diseases is one of the biggest challenges in biopharma today. With tiny patient populations, fragmented data, and fast-evolving treatment landscapes, traditional forecasting models often fall short. This white paper unpacks why forecasting in rare diseases demands an entirely different mindset, and how companies can evolve their methodologies, tools, and culture to keep pace.

LLM-Powered Structured Data Extraction from Thymoma Reports

Admin — Tue, 19 Aug 2025 07:55:11 GMT

Manual abstraction of pathology reports is one of the most time-consuming and error-prone tasks in clinical data workflows. With institutions employing dozens of specialists and spending hours per patient, the need for scalable automation is urgent.

Real-World Data Ecosystem & New Frontiers in Evidence Generation

Admin — Tue, 06 May 2025 05:55:20 GMT

The real-world data (RWD) landscape is transforming; rapidly expanding beyond traditional claims and EHR data to include wearables, genomics, formulary intelligence, social determinants of health, and patient-reported outcomes. These new sources, when combined with advancements in tokenization, cloud-based architecture, and AI-powered analytics (including the emergence of Agentic AI), are unlocking new frontiers in clinical evidence generation.